Published in TB and Outbreaks Week, November 7th, 2000
"The development of a malaria vaccine is a priority for improved and sustained malaria control," stated C.M. Galindo and colleagues. "Optimal use of a vaccine in Africa will only be achieved if it can be delivered through the Expanded Programme of Immunization (EPI).
"We have completed a trial of the peptide vaccine SPf66 in Tanzanian infants, given alongside the EPI vaccines," continued Galindo et al.
According to the researchers, 1,207 infants were recruited into their two-arm,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week